IMA
ImageneBio, Inc.
NASDAQ: IMA · HEALTHCARE · BIOTECHNOLOGY
$6.02
+1.52% today
Updated 2026-04-30
Market cap
$65.21M
P/E ratio
—
P/S ratio
81.51x
EPS (TTM)
$-9.64
Dividend yield
—
52W range
$4 – $18
Volume
0.4M
ImageneBio, Inc. (IMA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-11.61M | $47.93M | $-37.83M | $-60.25M | $-74.11M | $-79.74M | $-46.00M | $-47.84M |
| Capital expenditures | $305000.00 | $316000.00 | $766000.00 | $1.76M | $1.43M | $414000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $314000.00 | $1.17M | $1.80M | $5.18M | $7.53M | $7.63M | $5.29M | $15.39M |
| Free cash flow | $-11.91M | $47.61M | $-38.59M | $-62.01M | $-75.54M | $-80.16M | $-46.00M | $-47.84M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |